This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Following its release of strong revenue growth for the fourth quarter and full-year 2006, Qiagen officials said this week that the firm plans to expand its sample and assay portfolio and expects to make “a significant investment in clinical trials” for new diagnostic products.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.